REGULATED PRESS RELEASE published on 09/24/2024 at 14:40, 1 year 2 months ago Half-year financial report for the period ended 30 June 2024
BRIEF published on 09/23/2024 at 18:55, 1 year 2 months ago Peugeot Invest Reports H1 2024 Results: Enhanced Investment Capacity PEUGEOT INVEST Asset Disposals Investment Capacity H1 2024 Results Jean-Charles Douin CEO
REGULATED PRESS RELEASE published on 09/23/2024 at 18:50, 1 year 2 months ago First half Results: Active management and increased investment capacity Peugeot Invest reports active management and increased investment capacity in H1 2024, with CEO appointment and net profit of €228 million. NAV per-share €226.7, -3.7% from last year PEUGEOT INVEST CEO Appointment Net Profit Investment Capacity NAV Per-share
BRIEF published on 09/04/2024 at 17:40, 1 year 3 months ago Peugeot Invest - Number of shares and voting rights as of August 31, 2024 Voting Rights PEUGEOT INVEST Actions Regulation Thresholds
BRIEF published on 08/05/2024 at 17:51, 1 year 3 months ago Peugeot Invest: Declaration of the number of shares and voting rights Voting Rights Eurolist Peugeot Shares Legal Declaration Participation Threshold
BRIEF published on 07/24/2024 at 18:25, 1 year 4 months ago Jean-Charles Douin Appointed CEO of Peugeot Invest Private Equity PEUGEOT INVEST CEO Appointment Leadership Change Jean-Charles Douin
REGULATED PRESS RELEASE published on 07/24/2024 at 18:20, 1 year 4 months ago Jean-Charles Douin appointed CEO of Peugeot Invest Jean-Charles Douin appointed CEO of Peugeot Invest. With 20 years in private equity, he brings vast experience to lead the company's growth strategy Growth Strategy Private Equity PEUGEOT INVEST CEO Appointment Jean-Charles Douin
BRIEF published on 07/17/2024 at 17:50, 1 year 4 months ago Peugeot Invest Discloses Trading in Own Shares Annual General Meeting Euronext PEUGEOT INVEST Investment Share Trading
REGULATED PRESS RELEASE published on 07/17/2024 at 17:45, 1 year 4 months ago Disclosure of trading in own shares Peugeot Invest discloses trading in own shares between 8 and 10 July 2024, authorized by AGM. Company listed on Euronext reveals details of transactions Euronext PEUGEOT INVEST Trading Disclosure Own Shares
BRIEF published on 07/11/2024 at 17:50, 1 year 4 months ago Peugeot Invest Discloses Own Share Trading Euronext PEUGEOT INVEST Financial Disclosure Share Trading
Published on 12/05/2025 at 02:35, 7 hours 15 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 8 hours 50 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 45 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 50 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 09:40, 9 minutes ago Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 20 minutes ago REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 44 minutes ago Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 08:45, 1 hour 5 minutes ago Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/04/2025 at 18:00, 15 hours 50 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 16 hours 5 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 16 hours 6 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 1 day 2 hours ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
